- Home
- TRML vs MMI Comparison
TRML vs MMI Comparison
Compare TRML & MMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TRML
- MMI
- Stock Information
- Founded
- TRML 2021
- MMI 1971
- Country
- TRML United States
- MMI United States
- Employees
- TRML N/A
- MMI N/A
- Industry
- TRML Biotechnology: Pharmaceutical Preparations
- MMI Real Estate
- Sector
- TRML Health Care
- MMI Finance
- Exchange
- TRML Nasdaq
- MMI Nasdaq
- Market Cap
- TRML 1.2B
- MMI 1.2B
- IPO Year
- TRML N/A
- MMI 2013
- Fundamental
- Price
- TRML $47.90
- MMI $27.95
- Analyst Decision
- TRML Hold
- MMI Hold
- Analyst Count
- TRML 12
- MMI 1
- Target Price
- TRML $47.04
- MMI N/A
- AVG Volume (30 Days)
- TRML 2.1M
- MMI 116.7K
- Earning Date
- TRML 11-06-2025
- MMI 11-07-2025
- Dividend Yield
- TRML N/A
- MMI 1.73%
- EPS Growth
- TRML N/A
- MMI N/A
- EPS
- TRML N/A
- MMI N/A
- Revenue
- TRML N/A
- MMI $725,903,000.00
- Revenue This Year
- TRML N/A
- MMI $9.50
- Revenue Next Year
- TRML N/A
- MMI $17.73
- P/E Ratio
- TRML N/A
- MMI N/A
- Revenue Growth
- TRML N/A
- MMI 17.89
- 52 Week Low
- TRML $11.56
- MMI $27.61
- 52 Week High
- TRML $48.27
- MMI $42.80
- Technical
- Relative Strength Index (RSI)
- TRML 91.37
- MMI 26.76
- Support Level
- TRML $47.83
- MMI $28.25
- Resistance Level
- TRML $47.94
- MMI $29.38
- Average True Range (ATR)
- TRML 0.11
- MMI 0.70
- MACD
- TRML -0.63
- MMI -0.29
- Stochastic Oscillator
- TRML 38.14
- MMI 6.22
About TRML Tourmaline Bio Inc.
Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.
About MMI Marcus & Millichap Inc.
Marcus & Millichap Inc is a national brokerage firm specializing in commercial real estate investment sales, financing, research, and advisory services. The company offers three primary services to its clients: commercial real estate investment brokerage, financing, and ancillary services, including other research, advisory, and consulting services. The company generates revenues by collecting fees on the sale and financing of commercial properties. These fees consist of commissions collected upon the sale of a property and fees collected from the placement of loans.